Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Share :
Published: 26 Feb 2015
Views: 4557
Rating:
Save
Prof Thomas Powles - Barts Health, London, UK

Prof Powles talks to ecancertv at ASCO GU 2015 about the use of dual TORC1 and 2 inhibitors, such as AZD2014, in the treatment of renal cancer.